JPH06506002A - (+)−(1s,2r)−2−[[n−(2−ヒドロキシルアミノ−2−オキソエチル)−n−メチル−アミノ]カルボニル]シクロヘキサン−1−カルボン酸の安定な塩 - Google Patents

(+)−(1s,2r)−2−[[n−(2−ヒドロキシルアミノ−2−オキソエチル)−n−メチル−アミノ]カルボニル]シクロヘキサン−1−カルボン酸の安定な塩

Info

Publication number
JPH06506002A
JPH06506002A JP5511398A JP51139893A JPH06506002A JP H06506002 A JPH06506002 A JP H06506002A JP 5511398 A JP5511398 A JP 5511398A JP 51139893 A JP51139893 A JP 51139893A JP H06506002 A JPH06506002 A JP H06506002A
Authority
JP
Japan
Prior art keywords
amino
carbonyl
oxoethyl
methyl
cyclohexane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5511398A
Other languages
English (en)
Japanese (ja)
Inventor
ジヨルジ, ラフアエロ
スビシ,アレツサンドロ
トウルバンテイ,ルイジ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorio Guidotti SpA
Original Assignee
Laboratorio Guidotti SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorio Guidotti SpA filed Critical Laboratorio Guidotti SpA
Publication of JPH06506002A publication Critical patent/JPH06506002A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
JP5511398A 1991-12-23 1992-12-12 (+)−(1s,2r)−2−[[n−(2−ヒドロキシルアミノ−2−オキソエチル)−n−メチル−アミノ]カルボニル]シクロヘキサン−1−カルボン酸の安定な塩 Pending JPH06506002A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT91A003448 1991-12-23
ITMI913448A IT1252708B (it) 1991-12-23 1991-12-23 Sali stabili dell'acido (+)-(1r,2s)-2((n-(2-idrossilammino-2-ossoetil)-n-metilammino)carbonil)cicloesan-1-carbossilico,ad attivita' ace inibitrice, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
PCT/EP1992/002903 WO1993013056A1 (fr) 1991-12-23 1992-12-12 Sels stables de l'acide (+)-(1s,2r)-2-[[n-(2-hydroxylamino-2-oxoethyl)-n-methyl-amino]carbonyl]cyclohexane-1-carboxylique, procede de preparation et compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
JPH06506002A true JPH06506002A (ja) 1994-07-07

Family

ID=11361409

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5511398A Pending JPH06506002A (ja) 1991-12-23 1992-12-12 (+)−(1s,2r)−2−[[n−(2−ヒドロキシルアミノ−2−オキソエチル)−n−メチル−アミノ]カルボニル]シクロヘキサン−1−カルボン酸の安定な塩

Country Status (26)

Country Link
EP (1) EP0575572A1 (fr)
JP (1) JPH06506002A (fr)
CN (1) CN1079474A (fr)
AU (1) AU657591B2 (fr)
BG (1) BG98050A (fr)
BR (1) BR9205652A (fr)
CA (1) CA2104372A1 (fr)
CZ (1) CZ379692A3 (fr)
EE (1) EE9400006A (fr)
FI (1) FI933685A0 (fr)
HR (1) HRP921454A2 (fr)
HU (1) HUT69287A (fr)
IT (1) IT1252708B (fr)
LV (1) LV10426B (fr)
MA (1) MA22749A1 (fr)
MX (1) MX9207543A (fr)
NZ (1) NZ245547A (fr)
PL (1) PL169086B1 (fr)
PT (1) PT101156A (fr)
RU (1) RU2079489C1 (fr)
SI (1) SI9200409A (fr)
SK (1) SK379692A3 (fr)
TN (1) TNSN92117A1 (fr)
WO (1) WO1993013056A1 (fr)
YU (1) YU110892A (fr)
ZA (1) ZA9210004B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264860B1 (it) * 1993-06-21 1996-10-17 Guidotti & C Spa Labor Derivati di acidi cis- e trans-2(((2-(isdrossiammino)-2-ossoetil)- alchilammino)carbonil)cicloesancarbossilici
US5639746A (en) * 1994-12-29 1997-06-17 The Procter & Gamble Company Hydroxamic acid-containing inhibitors of matrix metalloproteases
FR2817241B1 (fr) 2000-11-30 2003-03-07 Cebal Tube aluminium avec embout secable
CN101516191A (zh) * 2006-09-28 2009-08-26 默克公司 Saha的胺碱盐和其多晶型物
CN114845603B (zh) 2020-04-27 2025-01-24 卡特-霍夫曼有限责任公司 用于柜的门移动系统

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1224627B (it) * 1988-04-12 1990-10-04 Guidotti & C Spa Labor Ammidi di acidi ciclometilen_1,2_dicarbossilici adattivita' terapeutica, procedimenti per la loro preparazione e composizioni farmaceutiche che le contengono.

Also Published As

Publication number Publication date
MX9207543A (es) 1993-08-01
AU657591B2 (en) 1995-03-16
AU3087192A (en) 1993-07-28
SI9200409A (en) 1993-09-30
CN1079474A (zh) 1993-12-15
ITMI913448A1 (it) 1993-06-23
RU2079489C1 (ru) 1997-05-20
MA22749A1 (fr) 1993-07-01
NZ245547A (en) 1995-12-21
LV10426B (en) 1995-08-20
FI933685L (fi) 1993-08-20
FI933685A7 (fi) 1993-08-20
CA2104372A1 (fr) 1993-06-24
EP0575572A1 (fr) 1993-12-29
ZA9210004B (en) 1993-12-13
PL297118A1 (en) 1993-09-06
HU9302389D0 (en) 1993-11-29
PT101156A (pt) 1994-06-30
SK379692A3 (en) 1995-04-12
FI933685A0 (fi) 1993-08-20
ITMI913448A0 (it) 1991-12-23
BG98050A (bg) 1994-04-29
BR9205652A (pt) 1994-05-03
HRP921454A2 (en) 1995-02-28
WO1993013056A1 (fr) 1993-07-08
LV10426A (lv) 1995-02-20
EE9400006A (et) 1995-12-15
CZ379692A3 (en) 1993-09-15
HUT69287A (en) 1995-09-28
IT1252708B (it) 1995-06-26
YU110892A (sh) 1996-01-08
PL169086B1 (pl) 1996-05-31
TNSN92117A1 (fr) 1993-06-08

Similar Documents

Publication Publication Date Title
CA1270596A (fr) Derives peptidiques a structure polycyclique azotee et leur procede de preparation
CA1187087A (fr) Derives d'acide cis, endo-2-azabicyclo-[3.3.0]- octane-3-carboxylique; preparation, agents renfermant ces composes, et leur utilisation
JPS58172367A (ja) 二環式アミノ酸の新規な誘導体
JPH02500275A (ja) 潰瘍の予防のための方法及び組成物
JPH0645639B2 (ja) ペプチド誘導体
HU179734B (en) Process for producing pharmaceutically effective new n-2 above-bracket-1,2,3,4-tetrahydro-8-quinolyl-bracket closed-sulfonyl-l-arginine-amides
US3817973A (en) Process for the preparation of cyclopeptides derived from polymyxins
JPH06506699A (ja) 抗血栓性ペプチドおよび偽ペプチド
US20230087950A1 (en) Method for synthesizing dopa oligopeptide intermediate and use, composition and preparation thereof
JPWO2012133884A1 (ja) ボロン酸化合物を含有したブロック共重合体を含む医薬組成物
US3740439A (en) Treating hypertension with beta-aminoalkane carboxylic acids
JPS58109460A (ja) エンケフアリン誘導体
JPS59231054A (ja) L−5−ヒドロキシトリプトフアンの新規なジペプチド類およびそれらを製造する方法並びにそれらジペプチド類を含む薬剤
Kopple et al. Reactivity of cyclic peptides. III. Reaction of isomeric histidine, tyrosine peptides with p-nitrophenyl acetate
AU657591B2 (en) Stable salts of (+)-(1S,2R)-2-((N-(2-hydroxylamino-2-oxoethyl)-N-methyl- amino)carbonyl)cyclohexane-1-carboxylic acid, process for their preparation and pharmaceutical compositions containing them
AU661475B2 (en) N-((4,5-dihydroxy- and 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracene-yl) carbonyl)amino acids useful in the therapy of osteoarticular affections
FR2727315A1 (fr) Utilisation d'un decapeptide a activite de type benzodiazepine pour la preparation de medicaments et de complements alimentaires
US4837305A (en) Derivatives of β-adrenergic antagonists
JPH0832704B2 (ja) プロリルエンドペプチダーゼ阻害剤
KR20240024963A (ko) 티아졸-락탐-스피로헤테로사이클릭 화합물 및 이의 적용
JPH031319B2 (fr)
JPH11505503A (ja) 有機塩基カチオンとの2−〔(2,6−ジクロロフェニル)アミン〕フェニルアセトキシ酢酸の新規の塩類
CA1257748A (fr) Derives n-acyl de peptides, procede de preparation et utilisation dans le traitement des troubles neurologiques et agents utilises a cette fin
JPS60120899A (ja) 化学的化合物
US3428679A (en) Tetracycline hydroxy carboxylic acids